Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
In the original publication of this article [1], there is a mistake in the Fig. 2a, 2b, and 2c.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
BMC,
2019-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | In the original publication of this article [1], there is a mistake in the Fig. 2a, 2b, and 2c. |
|---|---|
| Item Description: | 10.1186/s12913-019-4829-z 1472-6963 |